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        Introduction 
  Osteoclasts are multinucleated cells responsible for bone re-
sorption ( Martin et al., 1998 ;  Roodman, 1999 ;  Chambers, 2000 ). 
Hemopoietic cells of the monocyte/macrophage lineage dif-
ferentiate into osteoclasts under the strict control of bone-
forming osteoblasts (  Suda et al., 1999  ;   Takahashi et al., 2002  ). 
Osteoblasts express two cytokines essential for osteoclast dif-
ferentiation, macrophage colony-stimulating factor (M-CSF) 
and receptor activator of NF-    B (RANK) ligand (RANKL; 
  Suda et al., 1999  ;   Arron and Choi, 2000  ;   Hofbauer et al., 2000  ; 
  Takahashi et al., 2002  ;   Boyle et al., 2003  ). M-CSF is constitu-
tively produced by osteoblasts. Osteopetrotic op/op mice can-
not produce functionally active M-CSF as a result of an extra 
thymidine in the coding region of the M-CSF gene. Osteoclast for-
mation is severely suppressed in op/op mice (  Felix et al., 1990  ; 
  Wiktor-Jedrzejczak et al., 1990  ;   Yoshida et al., 1990  ;   Kodama 
et al., 1991  ). However, RANKL is inducibly expressed as a 
membrane-associated factor by osteoblasts in response to osteo-
tropic hormones such as parathyroid hormone (PTH) and 1   ,25-
dihydroxyvitamin D  3   (1  ,25(OH) 2 D 3  ;   Suda et al., 1999  ). 
RANKL-defi  cient (RANKL 
   /    ) mice also exhibit severe osteo-
petrosis because of a lack of osteoclasts (  Kong et al., 1999  ; 
  Suda et al., 1999  ;   Arron and Choi, 2000  ;   Hofbauer et al., 2000  ; 
  Takahashi et al., 2002  ;   Boyle et al., 2003  ). Osteoclast precursors 
such as bone marrow  –  derived macrophages (BMM   )  express 
c-Fms (M-CSF receptors) and RANK (RANKL receptors), 
recognize RANKL expressed by osteoblasts through cell  –  cell 
interaction, and differentiate into osteoclasts in the presence 
of M-CSF. Although the mechanisms by which the monocyte/
macrophage lineage cells differentiate into osteoclasts are 
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steoclasts are multinucleated cells that resorb 
bone. Although osteoclasts originate from the 
monocyte/macrophage lineage, osteoclast pre-
cursors are not well characterized in vivo. The relation-
ship between proliferation and differentiation of osteoclast 
precursors is examined in this study using murine macro-
phage cultures treated with macrophage colony-stimulating 
factor (M-CSF) and receptor activator of NF-    B (RANK) 
ligand (RANKL). Cell cycle  –  arrested quiescent osteoclast 
precursors (QuOPs) were identiﬁ  ed as the committed 
osteoclast precursors in vitro. In vivo experiments show that 
QuOPs survive for several weeks and differentiate into 
  osteoclasts in response to M-CSF and RANKL. Adminis-
tration of 5-ﬂ   uorouracil to mice induces myelosuppres-
sion, but QuOPs survive and differentiate into osteoclasts 
in response to an active vitamin D  3   analogue given to 
those mice. Mononuclear cells expressing c-Fms and 
RANK but not Ki67 are detected along bone surfaces in 
the vicinity of osteoblasts in RANKL-deﬁ  cient mice. These 
results suggest that QuOPs preexist at the site of osteo-
clastogenesis and that osteoblasts are important for main-
tenance of QuOPs.
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  In this study, we examined the relationship between pro-
liferation and differentiation of osteoclast precursors in murine 
BMM     cultures and identifi  ed cell cycle  –  arrested quiescent 
  osteoclast precursors (QuOPs) as the committed osteoclast pre-
cursors. In vivo experiments showed that QuOPs detected in 
bone had a long lifespan and promptly differentiated into osteo-
clasts in response to bone resorption-inducing stimuli. Like 
HSCs, QuOPs showed marked resistance to 5-FU treatment and 
preexisted along bone surfaces in the close vicinity of osteo-
blasts. Our results provide the fi  rst description of cell cycle  –
    arrested osteoclast precursors in vivo. 
  Results 
  Cell cycle arrest in osteoclast precursors 
is a prerequisite step for their 
differentiation into osteoclasts 
 BMM   (osteoclast precursors) differentiated into TRAP 
+  multi-
nucleated osteoclasts within 3 d in the presence of M-CSF and 
RANKL ( Fig. 1 A ). The growth of BMM   treated with RANKL 
and M-CSF was retarded on days 2 and 3 in comparison with 
that of M-CSF alone (  Fig. 1 A  , left). The levels of cyclins D1, 
D2, D3, and E1 and Cdk2, 4, and 6 gradually decreased after 
treatment with M-CSF and RANKL (  Fig. 1 B  ). On day 3, cul-
tures treated with M-CSF and RANKL still contained small 
amounts of cyclins D3 and E1 and Cdk2, 4, and 6. Using puri-
fi  ed osteoclasts, we further examined whether mature osteo-
clasts express cyclins and Cdks. Purifi  ed osteoclasts (purity of 
osteoclasts,     95%;   Akatsu et al., 1992  ) failed to express cyclins 
D1, D2, D3, and E1 and Cdk2 and 4 (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200806139/DC1). Cdk6 was 
weakly expressed in purifi  ed osteoclasts. The expression of Cdk 
inhibitors p27 
KIP1   and  p21 
CIP1   was reported to be up-regulated 
during osteoclast differentiation (  Okahashi et al., 2001  ;   Sankar 
et al., 2004  ). BMM     showed that the expression of p27 
KIP1  
but not of p21 
CIP1   was up-regulated in the presence of RANKL 
(  Fig. 1 B  ). Real-time PCR analysis confi  rmed that the levels of 
p21 
CIP1   and  p27 
KIP1   mRNA in osteoclast precursors refl  ected the 
changes in p21 
CIP1   and p27 
KIP1   protein levels during their differ-
entiation into osteoclasts (  Fig. 1 C  ). These results suggest that 
cell cycle arrest in mature osteoclasts is maintained by the dis-
appearance of cyclins and Cdks and that p27 
KIP1   rather  than 
p21 
CIP1   is involved in RANKL-induced osteoclastic differentia-
tion of BMM   . 
  When hydroxyurea (HU), an inhibitor of DNA replica-
tion, was added to the culture on day 0, RANKL-induced osteo-
clast formation was completely inhibited (  Fig. 2 A  ). In contrast, 
the formation of osteoclasts was accelerated by HU when it was 
added on day 1 (  Fig. 2 A  ). HU added on day 2 had no effect on 
osteoclast formation. BrdU is a nucleoside analogue that can be 
incorporated into dividing nuclei. When BrdU was added to 
BMM     cultures together with RANKL on day 0, all of the nu-
clei in RANKL-induced multinucleated cells were labeled with 
BrdU (  Fig. 2 B  ). When BrdU was added on day 1 (1 d after 
treatment with RANKL), only 20% of the nuclei of multinucle-
ated cells incorporated BrdU (  Fig. 2 B  ). Ki67 is a marker of ac-
tively cycling cells (  Gerdes et al., 1984  ). Most nuclei of BMM    
well defi  ned, the characteristics of the osteoclast precursors in 
vivo have remained unclear. 
 Using  RANKL 
   /     mice and a system involving bone 
morphogenetic protein 2 (BMP-2)  –  induced ectopic bone for-
mation, we previously examined how the site of osteoclasto-
genesis is determined (  Yamamoto et al., 2006  ). Collagen disks 
containing BMP-2 (BMP-2 disks) or vehicle were implanted 
into RANKL 
   /     mice, which were i.p. injected with RANKL 
for 7 d. Tartrate-resistant acid phosphatase (TRAP; a marker 
enzyme of osteoclasts)  –  positive (TRAP 
+  ) osteoclasts and alkaline 
phosphatase (ALP; a marker enzyme of osteoblasts)  –  positive 
(ALP 
+  ) osteoblasts simultaneously appeared in the BMP-2 disks 
but not in the control disks. TRAP 
+   osteoclasts were located in 
close proximity to ALP 
+   osteoblasts. These results suggest that 
osteoblasts also play important roles in osteoclastogenesis by pro-
viding a suitable microenvironment for the action of RANKL. 
Recent studies have established that immunoreceptor tyrosine-
based activation motif  –  mediated signals act as a costimulatory 
signal in RANKL-induced osteoclastogenesis (  Kim et al., 2002  ; 
  Koga et al., 2004  ). Osteoblasts are proposed to express the 
putative ligand for immunoglobulin-like receptors, which in-
duces signals mediated by immunoreceptor tyrosine-based 
ac tivation  motif – containing  molecules.  These  results  suggest 
that, besides M-CSF and RANKL, unknown osteoblast-derived 
factors and ligands for immunoglobulin-like receptors may be 
involved in the determination of the correct location of osteo-
clast formation. 
  Hematopoietic stem cells (HSCs) have self-renewal 
capacity and multilineage developmental potentials (  Wilson 
and Trumpp, 2006  ). A specifi  c microenvironment in bone, 
called a stem cell niche, is proposed to sustain HSCs in an 
immature state so that their numbers can be maintained with-
out a loss of properties. HSCs that exist in the niche are shown 
to be resistant to treatment with 5-fl  uorouracil (5-FU), which 
induces apoptosis in proliferating cells (  Heissig et al., 2002  ; 
  Arai et al., 2004  ). Recent studies have shown that HSCs are 
located in the trabecular endosteum area where osteoblasts 
play a critical role in maintaining quiescent HSCs (  Zhang 
et al., 2003  ;   Arai et al., 2004  ). It was also shown that PTH, 
through activation of the PTH/PTH-related peptide receptor 
in osteoblasts, could alter the HSC niche, resulting in the 
expansion of HSCs in vivo and in vitro (  Calvi et al., 2003  ). 
These results suggest that osteoblasts also play a role in the 
regulation of hematopoiesis. 
  Cell proliferation and differentiation are coordinated pro-
cesses in the development of specialized cells. Cell proliferation 
is driven by heterodimeric kinases composed of a cyclin, a regu-
latory subunit, and a Cdk, a catalytic subunit (  Morgan, 1995  ; 
  Sherr and Roberts, 1999  ). However, Cdk inhibitors such as the 
Cip/Kip family (p21 
CIP1 ,  p27 
KIP1  , and p57 
KIP2  ) regulate the ac-
tivity of Cdks (  Sherr and Roberts, 1995  ,   1999  ;   Sherr, 1996  ; 
  Nakayama, 1998  ;   Pavletich, 1999  ). Both cell cycle progression 
and withdrawal are tightly controlled by these cell cycle regula-
tory molecules. Recent studies have shown that p27 
KIP1 -  and 
p21 
CIP1  -induced cell cycle withdrawal in osteoclast precursors 
is important for their differentiation into osteoclasts (  Okahashi 
et al., 2001  ;   Sankar et al., 2004  ). 543 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
cycle regulatory molecules using a retroviral vector system. 
D-type cyclins are shown to associate with Cdk4 or 6 (  Weinberg, 
1995  ;   Morgan, 1997  ;   Classon and Harlow, 2002  ). Coexpression of 
cyclin D1 and Cdk4 in BMM     suppressed osteoclast formation 
were stained with anti-Ki67 antibody. In contrast, all of the 
  nuclei in osteoclasts were negative for Ki67 (Ki67 
     ;   Fig. 2 C  ). 
To confi  rm that regulation of the cell cycle is a key determinant 
in osteoclast differentiation, BMM     were transduced with cell 
  Figure 1.       Regulation of cell cycle during differentiation of BMM     into osteoclasts.   (A) Time course of changes in cell growth and TRAP 
+   osteoclast for-
mation in BMM     cultures. Bone marrow cells were cultured with 10 
4   U/ml M-CSF for 4 d to prepare BMM    . BMM     were further cultured with or without 
100 ng/ml RANKL in the presence of 10 
4   U/ml M-CSF. After culturing for the indicated periods, cell growth was measured by the AlamarBlue assay (Invitrogen) 
and expressed as the increase in ﬂ  uorescence emission at 590 nm (excitation wavelength, 560 nm) relative to the control at day 0 (left). In the other culture 
treated with RANKL and M-CSF, cells were ﬁ  xed and stained for TRAP (right). TRAP 
+   multinucleated cells containing more than three nuclei were counted 
as osteoclasts (bars). Results are expressed as the mean   ±   SD for six cultures. *, P   <   0.01; signiﬁ  cantly different from the culture treated with M-CSF alone. 
(B) Expression of cell cycle regulatory molecules and osteoclast-speciﬁ  c molecules in BMM     cultured with M-CSF or M-CSF plus RANKL. BMM     were cultured 
with 10 
4   U/ml M-CSF or 10 
4   U/ml M-CSF plus RANKL (100 ng/ml). After the indicated periods, cell lysates were prepared and subjected to immunoblot 
analyses of the indicated cell cycle regulatory molecules. Cell lysates were also analyzed for osteoclast-speciﬁ  c markers such as carbonic anhydrase II and 
cathepsin K. (C) Real-time PCR analysis of expression of p21 
CIP1   and p27 
KIP1   mRNAs in BMM    . BMM     were cultured with 10 
4   U/ml M-CSF or10 
4   U/ml 
M-CSF plus100 ng/ml RANKL. After the indicated periods, total RNA was extracted from cells. Expression levels of p21 
CIP1   and p27 
KIP1   mRNAs were esti-
mated by quantitative real-time RT-PCR. Dashed lines indicate control levels. Results are expressed as the relative expression of p21 
CIP1   and p27 
KIP1   mRNAs 
compared to the control at day 0. *, P   <   0.05. Error bars indicate mean   ±   SD for three experiments.     JCB • VOLUME 184 • NUMBER 4 • 2009  544
  Figure 2.       Relationship between cell cycle progression and arrest in BMM     during differentiation into osteoclasts.   (A) Effect of HU on osteoclastic 
differentiation of BMM    . The experimental protocol is illustrated in the top left. BMM     were cultured with 10 
4   U/ml M-CSF and100 ng/ml RANKL. 
100   μ  M HU was added to the culture on days 0, 1, or 2. After culturing for 3 d, cells were ﬁ  xed and stained for TRAP (right). TRAP 
+   multinucleated cells 
containing more than three nuclei were counted as osteoclasts (bottom left). *, P   <   0.01; signiﬁ  cantly different from the culture incubated without HU. 
(B) Nuclear labeling of osteoclasts with BrdU. BMM     were cultured with10 
4   U/ml M-CSF and100 ng/ml RANKL. 10 nM BrdU was added to the culture 
on days 0 and 1. After culturing for 3 d, cells were ﬁ  xed and stained with antibodies against BrdU (right). Arrows indicate BrdU 
+   nuclei in RANKL-
induced multinucleated cells in cultures treated with BrdU on day 1. BrdU 
+   and BrdU 
      nuclei in multinucleated cells containing more than three nuclei 
were counted. Percentages of nuclei labeled with BrdU were determined (left). *, P   <   0.01; signiﬁ  cantly different from the culture treated with BrdU on 
day 0. (C) Immunostaining of Ki67 in BMM     and osteoclasts. BMM     were cultured with 10 
4   U/ml M-CSF and 100 ng/ml RANKL for 3 d to produce 545 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
tered i.p. into 3-wk-old RANKL 
   /     mice for 2 d (one injection/
day;   Fig. 4, A and B  ). BrdU was also i.p. injected into RANKL 
   /    
mice (1 mg/injection/day) because toothless RANKL 
   /     mice 
were maintained with a water-containing paste diet. Osteo-
clasts were totally absent in tibiae of RANKL 
   /     mice (  Fig. 
4 A  , top). The injection of RANKL into RANKL 
   /     mice gen-
erated many TRAP 
+   cells in tibiae (  Fig. 4 A  , bottom). BrdU 
+  
nuclei were similarly observed in chondrocytes in growth 
plates in RANKL 
   /     mice injected with RANKL (  Fig. 4, A   
[middle] and   B   [left]). Although many multinucleated osteo-
clasts were generated by the injection,   >  70% of the nuclei in 
the osteoclasts did not incorporate BrdU (  Fig. 4, A and B  , 
right). This suggests that RANKL induced the differentia-
tion of preexisting QuOPs in bone tissues into osteoclasts in 
RANKL 
   /     mice. 
  M-CSF is believed to be involved in the proliferation as 
well as differentiation of osteoclast progenitors in mice. There-
fore, we examined whether M-CSF  –  induced osteoclasts are 
formed from QuOPs in M-CSF  –  defi  cient op/op mice. M-CSF 
(2   ×   10 
6   U/injection) and BrdU (1 mg/injection) were injected 
i.p. into 3-wk-old op/op mice for 7 d (one injection/day;   Fig. 4, 
C and D  ). Most of the nuclei of chondrocytes (    95%) in growth 
plates were labeled with BrdU in op/op mice with or without 
M-CSF treatment because of the long period (7 d) of BrdU ad-
ministration (  Fig. 4, C   [middle] and   D   [left]). Osteoclasts are 
hardly detected in 3-wk-old op/op mice (  Fig. 4 C  , top). The in-
jection of M-CSF into op/op mice generated many TRAP 
+   cells 
in contact with bone surfaces of tibiae (  Fig. 4 C  , bottom). Inter-
estingly, only 15% of nuclei in M-CSF  –  induced osteoclasts 
  incorporated BrdU in op/op mice (  Fig. 4, C   [right] and   D   [right]), 
suggesting that most osteoclasts were formed from QuOPs in 
response to M-CSF in op/op mice. These results also suggest 
that M-CSF as well as RANKL is not involved in the appear-
ance of QuOPs in mice. 
 We further examined whether the differentiation of QuOPs 
into osteoclasts is linked to the regulation of calcium metabo-
lism in wild-type mice. 7-wk-old mice were fed a low calcium 
diet for 3 d to induce osteoclastic bone resorption with the ad-
ministration of BrdU in drinking water. The number of osteo-
clasts in tibiae and serum activity of TRAP5b, a marker of 
osteoclastic bone resorption, were signifi  cantly increased in the 
mice fed a low calcium diet (Fig. S3, available at http://www
.jcb.org/cgi/content/full/jcb.200806139/DC1). However, the per-
centage of BrdU 
+   nuclei in osteoclasts remained unchanged. 
These results suggest that osteoclasts produced by feeding on a 
low calcium diet are formed from QuOPs. 
  Identiﬁ  cation of QuOPs as 5-FU  –  insensitive 
cells 
  The aforementioned data suggest that, like hemopoietic stem 
cells, cell cycle  –  arrested QuOPs should be resistant to 5-FU 
that induces apoptosis of cells having high proliferative potential 
induced by RANKL and M-CSF, whereas the expression of 
p27 
KIP1   stimulated it (Fig. S2, A and B, available at http://www
.jcb.org/cgi/content/full/jcb.200806139/DC1). These results sug-
gest that cell cycle progression and subsequent withdrawal in 
osteoclast precursors are required for their differentiation into 
osteoclasts in vitro. The committed osteoclast precursors were 
named cell cycle  –  arrested QuOPs. 
  RANK-mediated signals may switch on the cell cycle 
  arrest in osteoclast progenitors. To address this issue, primary 
osteoblasts were infected with a retrovirus carrying cDNA for 
RANK (Fig. S2 C). Neither down-regulation of cyclin D1 and 
Cdk4 expression nor up-regulation of p27 
KIP1   expression  was 
observed in RANK-transfected osteoblasts, even in the pres-
ence of RANKL. Osteoblasts expressing functional RANK 
proliferated similarly in the presence and absence of RANKL 
(Fig. S2 C). These results suggest that RANKL-induced cell 
cycle arrest is cell type specifi  c. 
  BrdU labeling of osteoclasts in vivo 
  We next examined in vivo labeling of nuclei of osteoclasts 
with BrdU. BrdU in 1 mg/ml drinking water was adminis-
tered for 1 wk to mice at different developmental stages, and 
the incorporation of BrdU into the nuclei of osteoclasts was 
evaluated in tibiae (  Fig. 3  ). When pregnant mice at 13.5 d 
postcoitum (embryonic day 13.5 [E13.5]) were given BrdU 
in drinking water for 1 wk,     50% of the nuclei of osteoclasts 
in newborn mice were labeled with BrdU. Similarly, 3- and 
7-wk-old mice were given BrdU in drinking water for 1 wk. 
About 30% of the nuclei of osteoclasts were labeled with 
BrdU in 4-wk-old mice. In contrast, most nuclei of osteo-
clasts were BrdU negative (BrdU 
     ) in 8-wk-old mice. Thus, 
the BrdU labeling of osteoclasts was inversely correlated 
with the growth of mice (  Fig. 3 A  ). We then examined the 
lifespan of QuOPs in adult mice. When 7-wk-old mice were 
given BrdU for an additional 7 wk, only 50% of the nuclei of 
osteoclasts were labeled with BrdU (  Fig. 3 B  ). Most of the 
bone marrow cells around osteoclasts were BrdU positive 
(BrdU 
+  ) in mice treated with BrdU for 7 wk. Previous studies 
have shown that the lifespan of osteoclasts is 2  –  4 wk in hu-
mans and mice (  Kodama et al., 1993  ;   Riggs and Parfi  tt, 
2005  ). These results suggest that the lifespan of QuOPs is at 
least 4 wk longer. 
  Differentiation of QuOPs into osteoclasts 
in vivo 
  We next examined whether osteoclasts are formed from cell 
cycle  –  arrested QuOPs in response to several stimuli. Osteo-
clasts are totally absent in RANKL 
   /     mice. Injection of 
RANKL into RANKL 
   /     mice induces osteoclasts along 
bone surfaces (  Yamamoto et al., 2006  ). We fi  rst examined 
whether RANKL-induced osteoclasts are formed from QuOPs 
in RANKL 
   /     mice. RANKL (15   μ  g/injection) was adminis-
osteoclasts. (right) BMM     and BMM     treated with M-CSF and RANKL for 3 d were stained with anti-Ki67 antibody (red), and the nuclei were also 
labeled with DAPI (blue). (left) Percentages of Ki67-positive nuclei in BMM     and RANKL-induced osteoclasts were determined. Results are expressed as 
the mean   ±   SD for three cultures. *, P   <   0.01; signiﬁ  cantly different from the BMM    .     
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5-FU (250 mg/kg body weight). The number of bone marrow 
cells was markedly decreased on day 6 after the injection 
(  Fig. 5 A  ). Mice pretreated with 5-FU for 6 d were i.p. given 
(  Heissig et al., 2002  ;   Arai et al., 2004  ). We then examined 
the effects of 5-FU on the differentiation of QuOPs into osteo-
clasts in mice (  Fig. 5  ). 7-wk-old mice were injected i.v. with 
  Figure 3.       Incorporation of BrdU into nuclei of osteoclasts in vivo.   (A) BrdU incorporation into nuclei in osteoclasts at different growth stages of mice. 
Pregnant mice at E13.5 and 3- and 7-wk-old mice were given 1 mg/ml BrdU in drinking water for 1 wk. Newborn, 4- , and 8-wk-old mice administered 
with BrdU for 1 wk were killed, and tibiae were recovered. Sections of tibiae were prepared and double stained for TRAP (red) and BrdU (brown). Arrows 
indicate the BrdU 
+   nuclei in osteoclasts (right). BrdU 
+   and BrdU 
      nuclei in osteoclasts were counted, and percentages of BrdU 
+   nuclei in osteoclasts were 
determined (left). Changes in the body weight of mice are shown. (B) BrdU incorporation into nuclei in osteoclasts in adult mice. 7-wk-old mice were given 
1 mg/ml BrdU in drinking water for 7 wk. Tibiae were recovered and subjected to TRAP and BrdU staining. Arrows indicate BrdU 
+   nuclei in osteoclasts 
(right). Percentages of BrdU 
+   nuclei in osteoclasts were determined (left). Results are expressed as the mean   ±   SD for three animals.     547 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
BrdU 
+   nuclei in osteoclasts remained unchanged by the in-
jection (  Fig. 5 B  ). Calcium concentrations and TRAP5b ac-
tivities in serum were signifi  cantly increased in response to 
2MD in 5-FU  –  pretreated mice (  Fig. 5 C  ). These results sug-
gest that 2MD-induced osteoclasts were formed from 5-FU  –
 insensitive  QuOPs. 
2MD (2-methylene-19-nor-1   ,25(OH) 2 D 3  ; a potent analogue 
of 1   ,25(OH) 2 D 3  ; 50 pmol/injection) for an additional 2 d 
with BrdU administered in drinking water. Expectedly, 2MD 
injected into 5-FU  –  pretreated mice signifi  cantly increased 
the number of TRAP 
+   osteoclasts in tibiae even under myelo-
suppressive conditions in bone (  Fig. 5 B  ). The percentage of 
  Figure 4.       Effects of RANKL and M-CSF on the incor-
poration of BrdU into nuclei of osteoclasts.   (A and B) 
Administration of RANKL to RANKL 
    /      mice. 3-wk-old 
RANKL 
    /      mice were i.p. injected with RANKL (15 
  μ  g/injection/day) together with BrdU (1 mg/injec-
tion/day) for 2 d. The ﬁ  rst injection of BrdU was per-
formed 3 h before the ﬁ  rst injection of RANKL. 24 h 
after the ﬁ  nal injection, the tibiae were recovered. 
(A) Sections of tibiae were prepared and double stained 
for TRAP (red) and BrdU (brown). Portions of the 
epiphyseal growth plate (middle) and trabecular bone 
(right) were observed at a higher magniﬁ  cation. (top) 
Osteoclasts were totally absent in RANKL 
    /      mice. 
(bottom) The administration of RANKL to RANKL 
    /      
mice induced osteoclasts to form in trabecular bones. 
(B, left) BrdU 
+   and BrdU 
      nuclei of chondrocytes in 
growth plates were counted, and percentages of 
BrdU 
+   nuclei in chondrocytes were calculated. (right) 
BrdU 
+   and BrdU 
      nuclei of RANKL-induced osteoclasts 
were counted, and percentages of BrdU 
+   nuclei in the 
osteoclasts were calculated. (C and D) Administration 
of M-CSF to op/op mice. 3-wk-old op/op mice were 
i.p. injected with M-CSF (2   ×   10 
6   U/injection/day) to-
gether with BrdU (1 mg/injection/day) daily for 7 d. 
The ﬁ  rst injection of BrdU was performed 3 h before 
the ﬁ  rst injection of M-CSF. 24 h after the ﬁ  nal injec-
tion, the tibiae were removed from the mice. (C) Sec-
tions of tibiae were prepared and double stained for 
TRAP (red) and BrdU (brown). Portions of epiphyseal 
growth plate (middle) and trabecular bone (right) were 
observed at a higher magniﬁ  cation. (top) Osteoclasts 
were totally absent in the tibiae of 3-wk-old op/op 
mice. (bottom) The administration of M-CSF to op/op 
mice induced osteoclasts to form in trabecular bones. 
(D, left) BrdU 
+   and BrdU 
      nuclei of chondrocytes in 
growth plates were counted and percentages of BrdU 
+   
nuclei in chondrocytes were calculated. (right) BrdU 
+   
and BrdU 
      nuclei of M-CSF  –  induced osteoclasts were 
counted, and percentages of BrdU 
+   nuclei in the os-
teoclasts were calculated. The results are expressed 
as the mean   ±   SD for three animals.     JCB • VOLUME 184 • NUMBER 4 • 2009  548
  Figure 5.       Effects of 5-FU administration on osteoclastic bone resorption induced by 2MD.   (A) Effects of 5-FU administration on hemopoietic cells in 
bone marrow. 7-wk-old mice were i.v. injected with 5-FU (250 mg/kg body weight). (left) On day 6 after injection, bone marrow cells obtained from 
the femora and tibiae were counted. Tibiae were also recovered from other 5-FU  –  treated and control mice. (right) Sections of tibiae were prepared and 
stained with hematoxylin-eosin. *, P   <   0.01; signiﬁ  cantly different from control mice. (B and C) Effects of 2MD administration on differentiation of QuOPs 
into osteoclasts. 7-wk-old mice were i.v. injected with 5-FU (250 mg/kg body weight). From day 6 after injection, mice were i.p. injected with 2MD (50 
pmol/injection/day) or vehicle for an additional 2 d with 1 mg/ml BrdU given in their drinking water. (B, right) The mice were killed, and blood and tibiae 
were recovered. Sections of tibiae were prepared and double stained for TRAP and BrdU. TRAP 
+   osteoclasts and BrdU 
+   and BrdU 
      nuclei in osteoclasts 549 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
(unpublished data). These results suggest that osteoblasts are 
involved in the maintenance of QuOPs in bone. 
  Discussion 
  In this study, we have demonstrated characteristics of cell cycle  –
  arrested QuOPs as the committed osteoclast precursors in vivo. 
QuOPs had a quite long lifespan associated with resistance to 
5-FU treatment and promptly differentiated into osteoclasts with-
out cell cycle progression in response to all the experimental con-
ditions tested. Mononuclear cells expressing c-Fms and RANK 
but not Ki67 (possibly QuOPs) were also   detected along bone 
surfaces in the vicinity of osteoblasts in RANKL 
   /     mice.  These 
results suggest that osteoblasts may play a role in maintaining 
QuOPs for a long period in an un  differentiated state. 
  Identiﬁ  cation of QuOPs as osteoclast 
precursors 
  Cell cycle withdrawal of BMM     during their differentiation 
into osteoclasts appeared to be associated with down-regulation 
of cyclins and Cdks and up-regulation of p27 
KIP1 .  Coexpression 
of cyclin D1 and Cdk4 in BMM     suppressed osteoclast forma-
tion, whereas the expression of p27 
KIP1   stimulated it. In addi-
tion,   Okahashi et al. (2001)   reported that RANKL up-regulated 
both p27 
KIP1   and  p21 
CIP1   expression in osteoclast precursors. 
  Sankar et al. (2004)   showed that p27 
KIP1   and p21 
CIP1   double-
knockout mice developed osteopetrosis with fewer osteoclasts. 
Forced expression of functional RANK in osteoblasts failed 
to induce cell cycle withdrawal. These results suggest that cell 
cycle arrest induced by RANKL is essential for osteoclastic dif-
ferentiation and is peculiar to osteoclast precursors. 
  QuOPs are proposed to express both c-Fms and RANK. In 
fact, c-Fms 
+ /RANK 
+   cells isolated from bone marrow differen-
tiated into osteoclasts even in the presence of HU. We further 
characterized the c-Fms 
+ /RANK 
+   cells isolated from bone 
marrow of wild-type mice in more detail (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200806139/DC1). 
Immunohistochemical staining showed that most of the c-Fms 
+ /
RANK 
+   cells were negative for F4/80 (Fig. S4 A). c-Fms 
+ /
RANK 
+   cells were cultured with lipopolysaccharide (LPS) to-
gether with M-CSF for 3 d, and the appearance of macrophages 
was evaluated by F4/80 staining. The number of F4/80-positive 
cells was not increased, even in cultures treated with LPS 
(Fig. S4 A). Both F4/80 
+   cells and RANK 
+   cells were detected 
in tibiae in wild-type mice, but cells double positive for RANK 
and F4/80 were rarely observed (Fig. S4 B). Phagocytic activity of 
c-Fms 
+ /RANK 
+   cells were much lower than that of BMM    
(Fig. S4 C). c-Fms 
+ /RANK 
+   cells were further cultured with 
LPS together with M-CSF for 3 d. The number of bead-positive 
cells was slightly increased from the initial value, but most of 
the cells (  ≥  80%) remained as nonphagocytic cells (Fig. S4 C). 
The ability of c-Fms 
+ /RANK 
+   cells to differentiate into dendritic 
  Identiﬁ  cation of QuOPs as double-positive 
cells for c-Fms and RANK in bone 
  The aforementioned data suggest that QuOPs are resistant to 
5-FU and are present in bone. QuOPs as well as osteoclasts are 
expected to express both M-CSF receptors (c-Fms) and RANKL 
receptors (RANK;   Miyamoto et al., 2000  ). Next, we examined 
whether the administration of 5-FU alters the population of 
c-Fms 
+ /RANK 
+   cells (c-Fms and RANK double-positive cells) 
in the bone marrow. 5-FU was i.v. injected into 7-wk-old mice. 
On day 8 after injection, bone marrow cells were collected and ana-
lyzed with a fl  ow cytometer (  Fig. 6  ). MOMA-2 
+ /CD11b 
+   cells 
(monocytes/macrophages) decreased in number with the in-
jection (  Fig. 6 A  , left). In contrast, 5-FU increased the Fms 
+ /
RANK 
+   cell population in the bone marrow cells (  Fig. 6 A  , 
right), suggesting that c-Fms 
+ /RANK 
+   cells were cell cycle ar-
rested. We then examined whether MOMA-2 
+ /CD11b 
+   cells 
and c-Fms 
+ /RANK 
+   cells can differentiate into osteoclasts with-
out proliferating. MOMA-2 
+ /CD11b 
+   cells differentiated into 
TRAP 
+   osteoclasts in response to M-CSF and RANKL in the 
absence but not presence of HU (  Fig. 6 B  ). In contrast, c-Fms 
+ /
RANK 
+   cells differentiated into TRAP 
+   cells even in the pres-
ence of HU (  Fig. 6 B  ). 
  Finally, we tried to detect c-Fms 
+ /RANK 
+   cells in bone tis-
sues in RANKL 
   /     mice because QuOPs but not osteoclasts are 
present in RANKL 
   /    mice ( Fig. 4, A and B ). Many mononuclear 
cells double positive for c-Fms and RANK (c-Fms 
+ /RANK 
+  
cells;   Fig. 7 A  , yellow) were detected along the surface of proximal 
tibiae in wild-type mice (  Fig. 7 A  , left, arrows). Double-positive 
multinucleated cells were also observed in the same regions 
(  Fig. 7 A  , asterisk). These multinucleated cells appeared to be 
  osteoclasts. QuOPs were shown to be resistant to 5-FU treatment 
(  Figs. 5 and 6  ). Coincidently, c-Fms 
+ /RANK 
+   mononuclear  cells 
were also detected even after treatment with 5-FU (  Fig. 7 A  , bot-
tom left). c-Fms 
+ /RANK 
+   mononuclear cells were detected along 
the surface of proximal tibiae in the RANKL 
   /     mice (  Fig. 7 A  , 
right). Because most RANK 
+  cells expressed c-Fms in RANKL 
   /    
mice, we examined the expression of Ki67, a marker of actively 
cycling cells. Most of the RANK 
+   cells (94%) were negative for 
Ki67 in RANKL 
   /     mice (  Fig. 7 A  , bottom right). 
 Osteoblasts may be involved in the maintenance of QuOPs 
in bone tissues. The distribution of ALP 
+   osteoblasts was com-
pared with that of RANK 
+   cells in RANKL 
   /     mice (  Fig. 7 B  ). 
ALP 
+   cells were distributed along the bone surface in trabecular 
bone. Hypertrophic chondrocytes also expressed ALP (  Fig. 7 B  , 
inset). The distribution of RANK 
+   cells was quite similar to that 
of ALP 
+   cells in the trabecular bone area. Higher magnifi  cation 
of this area showed that RANK 
+   cells were always present in 
the vicinity of ALP 
+   osteoblasts. The distribution of osteoblasts 
and proliferating cells adjacent to osteoblasts was determined 
using another cell proliferation marker, proliferating cell nu-
clear antigen. Most of the cells adjacent to ALP 
+   cells were neg-
ative for proliferating cell nuclear antigen in RANKL 
   /     mice 
were counted. (left) Percentages of BrdU 
+   nuclei in osteoclasts were calculated. (C) Serum calcium concentrations and TRAP5b activities were determined 
in 5-FU  –  treated mice injected with and without 2MD. (B and C) *, P   <   0.05; signiﬁ  cantly different from the 5-FU  –  injected mice. Results are expressed as 
the mean   ±   SD for three animals.     
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additional 7 wk, only 50% of the nuclei of osteoclasts were 
labeled with BrdU. The lifespan of osteoclasts is reported to be 
2  –  4 wk in humans and mice (  Kodama et al., 1993  ;   Riggs and 
Parfi  tt, 2005  ). These results suggest that the pool of QuOPs is 
much smaller in growing mice than adult mice and that the life-
span of QuOPs is quite longer than that of osteoclasts. In fact, 
most osteoclasts were formed from QuOPs in response to all the 
stimuli, such as the administration of RANKL in RANKL 
   /    
mice, the administration of M-CSF in op/op mice, the feeding 
of a low calcium diet in wild-type mice, and the administration 
of 2MD in 5-FU  –  pretreated mice. These results also suggest 
that neither M-CSF nor RANKL is involved in the proliferation 
of osteoclast progenitors and their differentiation into QuOPs 
in vivo. 
  Although M-CSF regulates growth and differentiation of 
monocyte/macrophage lineage cells in vivo, M-CSF  –  independent 
macrophages are shown to still be present in op/op mice (  Naito, 
1993  ;   Wiktor-Jedrzejczak and Gordon, 1996  ). QuOPs may be 
cells was much lower than that of BMM     (Fig. S4 D). In con-
trast to BMM   ,  c-Fms 
+ /RANK 
+   cells failed to proliferate in re-
sponse to M-CSF (unpublished data). These results suggest that 
c-Fms 
+ /RANK 
+   cells isolated from bone marrow are committed 
precursors in an osteoclast lineage. 
  We previously reported that postmitotic osteoclast precur-
sors were formed in cocultures of osteoblasts and bone marrow 
cells (  Tanaka et al., 1993  ;   Takahashi et al., 1994  ). Postmitotic 
osteoclast precursors differentiated into osteoclasts even in the 
presence of HU, suggesting that the postmitotic osteoclast pre-
cursors are QuOPs. c-Fms 
+ /RANK 
+   cells were also formed in 
the cocultures (unpublished data). These results suggest that 
osteoblasts may play a role in the differentiation of hematopoietic 
progenitors into QuOPs. 
  In vivo characterization of QuOPs 
  Percentages of BrdU 
+   nuclei in osteoclasts decreased with the 
growth of mice. When 7-wk-old mice were given BrdU for an 
  Figure 6.       Effects of 5-FU on changes in 
hemopoietic cell populations.   (A) Flow cytomet-
ric  analysis of bone marrow cells. 7-wk-old 
mice were injected with vehicle (top) or 5-FU 
(250 mg/kg body weight; bottom). 8 d after 
the injection, mice were killed. Bone marrow 
cells prepared from tibiae were analyzed for 
the expression of MOMA-2 and CD11b (left) 
and c-Fms and RANK (right). The numbers in 
the top right corners indicate percentages of 
MOMA-2 
+  /CD11b 
+   cells or of c-Fms 
+  /RANK 
+   
cells among all bone marrow cells. Results are 
expressed as the mean   ±   SD for three ani-
mals. (B) Effects of HU on osteoclast formation  .   
MOMA-2 
+  /CD11b 
+   cells and c-Fms 
+  /RANK 
+   
cells were isolated from bone marrow of wild-
type mice by magnetic cell sorting and cultured 
in the presence of 10 
4   U/ml M-CSF and 100 
ng/ml RANKL. 70   μ  M HU was added to some 
cultures. After 6 d of culture, cells were ﬁ  xed 
and stained for TRAP. TRAP 
+   multinucleated 
cells containing more than three nuclei were 
counted as osteoclasts. Results are expressed 
as the mean   ±   SD for six cultures. *, P   <   0.01; 
signiﬁ   cantly different from the culture incu-
bated without HU.     551 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
formed in cultures are somehow different from those of QuOPs 
in vivo. 
    Fischman and Hay (1962)   examined the origin of osteo-
clasts in regenerating salamander forelimbs. Osteoclasts fi  rst 
appeared in the regenerating limb on day 8 after amputation. 
Using  
3  H-thymidine, they showed that osteoclasts appearing 
in the limb are formed from precursors circulating in blood. 
  Osteoclast precursors did not proliferate in the regenerating limb. 
Osteoclasts labeled with  
3  H-thymidine were detected only when 
 
3  H-thymidine was administered to the salamander 1 d before the 
derived from such M-CSF  –  independent cells in vivo. RANKL 
and M-CSF were required to prepare QuOPs from BMM     in 
vitro in the absence of osteoblasts. In contrast to the QuOPs 
in vivo, we could not maintain the QuOPs, which were formed in 
BMM     cultures for   >  3 d with the capability to differentiate into 
osteoclasts in the absence of osteoblasts (unpublished data). 
In addition, our preliminary experiments showed that wild-type 
and RANKL 
   /     osteoblasts failed to maintain QuOPs in an un-
differentiated state for a long period in culture (unpublished 
data). These results suggest that the characteristics of QuOPs 
  Figure 7.       Localization of QuOPs in bone.  
(A) Localization of c-Fms 
+  /RANK 
+   and Ki67 
+   cells. 
Tibiae were recovered from 7-wk-old wild-type 
and 3-wk-old RANKL 
    /      mice. Sections of 
tibiae were prepared and subjected to double 
staining of RANK (green) and c-Fms (red; top 
and middle). Nuclei were labeled with DAPI 
(blue). Top panels show low power views of 
the specimens, and middle and bottom panels 
show high power views. (middle) The asterisk 
indicates a multinucleated osteoclast, which is 
surrounded by a small dotted line, and arrows 
indicate mononuclear cells double positive for 
RANK and c-Fms (yellow). Tibiae were also 
recovered from 7-wk-old wild-type mice pre-
treated with 5-FU for 6 d. (bottom left) Sections 
of tibiae from 5-FU  –  treated mice were stained 
for RANK (green), c-Fms (red), and DAPI (blue). 
The arrow indicates cells double positive for 
c-Fms and RANK in 5-FU  –  treated mice. (bottom 
right) Sections of tibiae from RANKL 
    /      mice 
were also stained for RANK (green), Ki67 
(red), and DAPI (blue). The arrow indicates a 
RANK 
+   and Ki67 
      cell. Bones are indicated 
by dashed lines. (B) Localization of RANK 
+   
cells and ALP 
+   cells. Sections of tibiae from 
RANKL 
    /      mice were subjected to staining 
of RANK (green), ALP (red), and DAPI (blue). 
Arrows and arrowheads indicate RANK 
+   and 
ALP 
+   cells, respectively. The inset shows a high 
power view of the boxed region.     JCB • VOLUME 184 • NUMBER 4 • 2009  552
  osteoblastic lineage function as a key component of the HSC 
niche controlling HSC numbers (  Calvi et al., 2003  ;   Zhang et al., 
2003  ). Osteoblasts may be involved in maintaining QuOPs as 
well as HSCs for a long period in a quiescent state. Unlike 
HSCs, QuOPs are cells with transient characteristics but with-
out a self-renewal capacity. The role of osteoblasts in an osteo-
clast niche may be different from that in the HSC niche. Further 
studies will elucidate the molecular mechanisms of the mainte-
nance of QuOPs in osteoclast niches. 
  Materials and methods 
  Animals and diet 
  6-wk-old male ddY mice, 3- and 7-wk-old male C57BL/6 mice, and pregnant 
C57BL/6 mice at E13.5 were obtained from Japan SLC. Cell cultures were 
performed using cells obtained from ddY mice. In vivo experiments were 
performed in C57BL/6 mice. Osteopetrotic (op/op) mice (C57BL/6) 
were obtained from The Jackson Laboratory. RANKL 
    /      mice (C57BL/6) 
were generated in one of the authors  ’   laboratories (  Kong et al., 1999  ). In 
some experiments, wild-type mice (C57BL/6), RANKL 
    /      mice, and op/op 
mice received i.p. injections of 2MD, RANKL (PeproTech), and M-CSF 
(Kyowa Hakko), respectively. 2MD was provided by M. Shimizu (Tokyo 
Medical and Dental University, Tokyo, Japan;   Yamamoto et al., 2003  ). 
All experiments were conducted in accordance with the guidelines for stud-
ies with laboratory animals of the Matsumoto Dental University Experimen-
tal Animal Committee. 
  Cultures of BMM     
  To obtain bone marrow macrophages, bone marrow cells obtained from 
tibiae of 6-wk-old ddY mice were cultured in     -MEM (Sigma-Aldrich) con-
taining 10% FBS (JRH Biosciences) in the presence of 10 
4   U/ml M-CSF. 
  After culture for 16 h, nonadherent cells were harvested, and 1.5   ×   10 
5   cells 
were incubated with 10 
4   U/ml M-CSF for 2 d in 48-well plates. Old media 
were replaced with fresh media containing M-CSF and further cultured for 
24 h. The adherent cells were used as BMM    . This time point was desig-
nated as day 0 in all the experiments. BMM     were further cultured with or 
without 100 ng/ml RANKL in the presence of 10 
4   U/ml M-CSF for 3 d. 
Some BMM     cultures were incubated with 100   μ  M HU (MP Biomedicals) 
or 10 nM BrdU (Sigma-Aldrich). After being cultured for the speciﬁ  c 
periods, cells were ﬁ  xed and stained for TRAP (  Takahashi et al., 1988  ). 
The BrdU incorporated into cells was detected by using a BrdU immuno-
histochemistry kit (Exalpha Biologicals). Images were obtained using A-Plan 
10   ×  /0.25 Ph1 and long-distance A-Plan 40   ×  /0.50 Ph2 objectives (Carl 
Zeiss, Inc.) on a microscope (Axiovert 200; Carl Zeiss, Inc.) with a digi-
tal camera (AxioCamHRc; Carl Zeiss, Inc.). Images were captured with 
amputation. These results suggest that QuOPs are formed in 
other hemopoietic tissues. 
  In vivo identiﬁ  cation of QuOPs 
 Using  RANKL 
   /     mice, we could identify QuOPs as c-Fms 
+ /
RANK 
+   cells. Most of the RANK 
+   cells were negative for Ki67 
in RANKL 
   /     mice. c-Fms 
+ /RANK 
+   cells were also detected in 
bone tissues in wild-type mice treated with 5-FU. These results 
confi  rmed the notion that QuOPs identifi  ed as c-Fms 
+ /RANK 
+  
cells in vivo are cell cycle – arrested cells. Like RANKL 
   /    mice, 
c-Fos knockout (c-Fos 
   /    ) mice exhibit severe osteopetrosis as 
a result of a lack of osteoclasts (  Wang et al., 1992  ). The distri-
bution of c-Fms 
+ /RANK 
+   cells was examined in bone tissues 
in c-Fos 
   /     mice (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200806139/DC1). Consistent with a previous 
study, F4/80 
+   cells were detected in proximal tibiae (  Grigoriadis 
et al., 1994  ). c-Fms 
+   cells were similarly observed along the 
bone surface. However, RANK 
+   cells were hardly observed in 
bone tissues in c-Fos 
   /     mice (Fig. S5). These results suggest 
that c-Fos signaling is important for the differentiation of hemato-
poietic cells into QuOPs. The abnormal bone resorption was 
observed in some genetically modifi  ed mice such as tumor necro-
sis factor-     transgenic mice (  Yao et al., 2006  ) and osteoprote-
gerin 
   /    mice ( Bucay et al., 1998 ;  Mizuno et al., 1998 ). Analysis 
of QuOPs in those mice may provide variable information on 
the mechanism of osteoclastogenesis. 
  Osteoclast niche prepared by osteoblasts 
  How do QuOPs recognize and settle at sites suitable for osteo-
clastogenesis? In preliminarily experiments, we observed that 
osteoclasts detected in BMP-2  –  induced ectopic bones are formed 
from circulating QuOPs (unpublished data). These results sug-
gest that hemopoietic tissues supply QuOPs, which reach the 
site where osteoclasts form through the blood stream. Osteo-
blasts may play a role in the homing of QuOPs to bone tissues. 
These homing and maintenance mechanisms occur in osteoclast 
niches (  Fig. 8  ). Recent studies have shown that cells of the 
  Figure 8.       Schematic representation of osteo-
clast niche.   Osteoclasts differentiate from 
monocyte/macrophage lineage cells through 
two sequential cell cycle  –  related events. Cell 
cycle  –  arrested QuOPs are the committed pre-
cursors of osteoclasts. Osteoclast precursors 
proliferate and differentiate into QuOPs in 
hemopoietic tissues. QuOPs reach osteoclast 
niches prepared by osteoblasts. QuOPs dif-
ferentiate into osteoclasts without cell cycle 
progression in response to all the stimuli that 
induce osteoclast formation. Osteoblasts may 
play a pivotal role in maintaining QuOPs for a 
long period in an undifferentiated state.     553 CELL CYCLE  –  ARRESTED OSTEOCLAST PRECURSORS   • Mizoguchi et al. 
  Flow cytometric analysis 
  Bone marrow cells obtained from femora were layered onto a Lympholyte-M 
gradient (Cedarlane Laboratories Ltd.). After centrifugation, mono  nuclear 
cells were collected and stained with anti-RANK (LOB14-8) antibody 
(Genetex, Inc.) and anti  –  c-Fms antibody. After two washes, cells were incu-
bated with phycoerythrin-conjugated anti  –  rat IgG and FITC-conjugated 
anti  –  rabbit IgG (Beckman Coulter). Collected mononuclear cells were 
also ﬁ  xed, permeabilized, and incubated with phycoerythrin-conjugated 
anti-CD11b antibody (M1/70; Beckman Coulter) plus FITC-conjugated 
anti  –  MOMA-2 antibody (Beckman Coulter). Stained cells were analyzed 
by Cytomics FC 500 (Beckman Coulter). Simultaneously, mononuclear cells 
in femurs and tibiae were counted using Flow-Count Fluorospheres (Beck-
man Coulter). 
  Measurements of serum TRAP5b activity and calcium 
  The serum TRAP5b activity was measured using a mouse TRAP assay kit 
(SBA Sciences). Serum calcium concentrations were measured using a cal-
cium E kit (Wako Chemicals USA, Inc.). 
  Isolation of c-Fms 
+  /RANK 
+   cells and MOMA-2 
+  /CD11b 
+   cells 
  Mononuclear cells obtained from femoral bone marrow were magnetically 
labeled with biotinylated anti-RANK antibodies conjugated to microbeads 
using a multiparameter magnetic cell-sorting Antibiotin Multisort kit (Mil-
tenyi Biotec). RANK 
+   cells were puriﬁ  ed using a positive selection column 
and a Multisort release reagent (Miltenyi Biotec). RANK 
+   cells were subse-
quently labeled with anti  –  c-Fms antibodies conjugated to microbeads using 
anti  –  rabbit IgG microbeads (Miltenyi Biotec). c-Fms 
+  /RANK 
+   cells were 
puriﬁ  ed using a positive selection column and a Multisort release reagent. 
MOMA-2 
+  /CD11b 
+   cells were similarly puriﬁ  ed from femoral bone mar-
row. Isolated c-Fms 
+  /RANK 
+   and MOMA-2 
+  /CD11b 
+   cells were cultured 
for 7 d with 10 
4   U/ml M-CSF and 100 ng/ml RANKL with or without 70   μ  M 
HU in 96-well plates (1.5   ×   10 
4   cells). 
  Statistical analysis 
  StatView software (version 5.0; SAS Institute, Inc.) was used for all statisti-
cal analyses. Data were evaluated by a one-way analysis of variance fol-
lowed by Fisher  ’  s protected least signiﬁ  cant difference test. The results of all 
experiments were expressed as the mean   ±   SD for 3  –  8 cultures. P   <   0.05 
was considered statistically signiﬁ  cant. Each experiment was repeated at 
least three times, and similar results were obtained. 
  Online supplemental material 
  Fig. S1 shows the expression of cell cycle regulatory molecules in BMM     
and puriﬁ  ed osteoclasts. Fig. S2 shows the effects of overexpression of 
cell cycle regulatory molecules in BMM     on osteoclastogenesis and ef-
fects of overexpression of RANK in osteoblasts on cell proliferation. Fig. S3 
shows the effects of feeding mice a low calcium diet on the incorpora-
tion of BrdU into nuclei of osteoclasts. Fig. S4 shows the character-
ization of c-Fms 
+  /RANK 
+   cells isolated from mouse bone marrow cells. 
Fig. S5 shows the analysis of QuOPs in c-Fos 
    /      mice. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/jcb
.200806139/DC1. 
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